Antibacterial Co(II), Ni(II), Cu(II) and Zn(II) complexes of Schiff bases derived from fluorobenzaldehyde and triazoles

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 5, 2006, Pages 557-562

  Singh, Kiran ^a  

^a KURUKSHETRA UNIVERSITY   (India)

Author keywords

1,2,4 triazoles; Antibacterial activity; Fluorobenzaldehyde; Metal chelates; Schiff bases

Indexed keywords

4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO 3 METHYL S TRIAZOLE COBALT; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO 3 METHYL S TRIAZOLE COPPER; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO 3 METHYL S TRIAZOLE NICKEL; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO 3 METHYL S TRIAZOLE ZINC; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO S TRIAZOLE COBALT; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO S TRIAZOLE COPPER; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO S TRIAZOLE NICKEL; 4 (4 FLUOROBENZALIDENEAMINO) 5 MERCAPTO S TRIAZOLE ZINC; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFUROXIME AXETIL; LINEZOLID; METAL COMPLEX; PROTON; SCHIFF BASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACILLUS SUBTILIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; GEOMETRY; INFRARED SPECTROMETRY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE ANALYSIS;

ANTI-BACTERIAL AGENTS; BENZALDEHYDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; METALS, HEAVY; MOLECULAR STRUCTURE; SCHIFF BASES; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE; TRIAZOLES;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33751079596     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600642131     Document Type: Conference Paper

References (39)

1. Yang, SW and Xu, L and Mierzwa, R and He, L and Terracciano, J and Patel, M and Gullo, V and Black, T and Zhao, W and Chan, T and Chu, M. (2004) Bioorg Med Chem, 12, pp. 3333-3338.
2. Sugie, Y and Hirai, H and Inagaki, T and Ishiguro, M and Kim, YJ and Kojima, Y and Sakakibara, T and Sakemi, S and Sugiura, A and Suzuki, Y and Brennan, L and Duignan, J and Huang, LH and Sutcliffe, J and Kojima, N. (2001) J Antibiotic, 54, pp. 911-916.
3. Lara, JG and Masalha, M and Foster, SJ. (2005) Drug Disc Today, 10, pp. 643-651.
4. Wright, GD. (2000) Chem Biol, 7, pp. R127-R132.
5. Travis, J and Potempa, J. (2000) Biochim Biophys Acta, 14, pp. 35-50.
6. Smith, HJ and Simons, C.(2001) Proteinase and peptidase inhibition: Recent potential targets for drug development. London: Taylor and Francis.
7. Rice, SA and Givskov, M and Steinberg, P and Kjelleberg, S. (1999) J Mol Microbiol Biotechnol, 1, pp. 23-31.
8. Scozzafava, A and Supuran, CT. (2000) J Med Chem, 43, pp. 3677.
9. Drabent, K and Bialoska, A and Ciunik, Z. (2004) Inorg Chem Commun, 7, pp. 224-227.
10. Singh, DP and Singh, K and Singh, PhA and Handa, RN. (2005) J Inst Chemists (India), 77, pp. 82.
11. Naik, AD and Annigeri, SM and Gangadharmath, UB and Ravankar, VK and Mahale, VB and Reddy, VK. (2002) Indian J Chem, 41A, pp. 2046-2053.
12. Sen, AK and Singh, G and Singh, K and Handa, RN and Dubey, SN and Squattirito, PJ. (1998) Proc Ind Acad Sci, 110, pp. 75-81.
13. Chohan, ZH and Pervez, H and Khan, KM and Supuran, CT. (2005) J Enz Inhib Med Chem, 20(1), pp. 81-88.
14. Michael, HP and Dines, C. (2004) J Mol Struct, 705, pp. 177-187.
15. Singh, K and Barwa, MS and Tyagi, P. (2006) Eur J Med Chem, 41(1), pp. 147-153.
16. Chohan, ZH and Pervez, H and Rauf, A and Scozzafava, A and Supuran, CT. (2002) J Enz Inhib Med Chem, 17(2), pp. 117-122.
17. Chohan, ZH and Scozzafava, A and Supuran, CT. (2002) J Enz Inhib Med Chem, 17(4), pp. 261-266.
18. Greenwood, D and Slack, R and Peutherer, J.(1997) Medical microbiology: A guide to microbial infections: Pathogensis, immunity, laboratory diagnosis and control 15th ed.
19. Vogel, AI.(1999) A text book of quantitative chemical analysis 5th ed. London: Addition Wesly Longman.
20. Bala, S and Gupta, RP and Sachdeva, ML and Singh, A and Pujari, HK. (1978) Ind J Chem, 16B, pp. 481.
21. NCCLS.(2000) Method for dilution antimicrobial susceptibility test for bacteria that grow aerobically approved standards 5th ed. Villanova, PA
22. McFarland, J. (1907) J Am Med Assoc, 14, pp. 1176-1178.
23. Singh, G and Singh, PhA and Singh, K and Singh, DP and Handa, RN and Dubey, SN. (2002) Proc Nat Acad Sci (India), 72A, pp. 87-94.
24. Shukla, PR and Singh, VK and Jaiswal, AM and Narain, J. (1983) J Ind Chem Soc, 60, pp. 321-324.
25. Gaur, S and Sharma, B. (2003) J Ind Chem Soc, 8, pp. 841-842.
26. Singh, K and Singh, RV and Tandon, JP. (1987) Synth React Inorg Met-Org Chem, pp. 385-398.
27. Daniel, TT and Natarajan, K. (2000) Transition Met Chem, 25, pp. 311. (Dordrecht, Neth.)
28. Sharma, BD and Bailar, JC. (1955) J Am Chem Soc, 77, pp. 5476-5480.
29. Nakamoto, K.(1997) Infrared spectra of inorganic and coordination compounds 5th ed. New York: Wiley Interscience. Part B
30. Lever, ABP.(1984) Inorganic electronic spectroscopy. Amsterdam: Elsevier.
31. Saied, MEK. (1994) Ind J Chem, 33A, pp. 830-836.
32. Balhausen, CJ.(1962) An introduction to ligands field. New York: McGraw Hill.
33. Jhaumeer-Laulloo, BS and Bhowon, MG. (2003) Ind J Chem, 42A, pp. 2536-2540.
34. Dubey, SN and Vaid, BK. (1992) Ind J Chem, 31A, pp. 199-201.
35. Sharma, PK and Sen, AK and Dubey, SN. (1994) Ind J Chem, 33A, pp. 1031-1033.
36. Chohan, ZH and Supuran, CT and Scozzafava, A. (2004) J Enz Inhib Med Chem, 19(1), pp. 79-84.
37. Chohan, ZH and Praveen, M. (2000) Synth React Inorg Met-Org Chem, 30(1), pp. 175-182.
38. Chohan, ZH and Praveen, M. (2001) Appl Organomet Chem, 15, pp. 617-625.
39. Chohan, ZH and Hassan, MUI and Khan, KM and Supuran, CT. (2005) J Enz Inhib Med Chem, 20(2), pp. 183-188.